Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098369 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
A Phase 4 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 444
- Enrollment target
NCT02098369: Completed Phase 4 study, sponsored by University of Illinois at Chicago.
NCT02098369 is a Phase 4 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 444 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02098369, a Phase 4 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 444 participants
- Enrollment target
Study Summary
About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).
Primary Outcome
Number of individuals who used the stationary concentrator for a mean of at least 17.7 hours per day
Interventions
- BEHAVIORAL Written education material (basic)
- BEHAVIORAL Additional education material
- BEHAVIORAL PELICAN-Proactive
- BEHAVIORAL PELICAN-Reactive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-10 |
| Phase | Phase 4 |
What the finished NCT02098369 record still lists
NCT02098369 is an interventional study that assigns participants to a tested intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 4 interventions - of which Written education material (basic) is the first listed.
NCT02098369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02098369 about?
NCT02098369 is a clinical study titled "Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers". About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of th...
What is the current status of trial NCT02098369?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 444 participants. The study started on 2015-04. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02098369?
The interventions under investigation include: Written education material (basic) (BEHAVIORAL), Additional education material (BEHAVIORAL), PELICAN-Proactive (BEHAVIORAL), PELICAN-Reactive (BEHAVIORAL).
Who is sponsoring clinical trial NCT02098369?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02098369's enrollment target sits among peer trials
444 190th of 2000 higher than 1,811 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia